Table 2:
Sample size | Year | Age range, years | Men (%) | Scoring criteria | Nasal pressure | AHI ≥5 events per h |
AHI ≥15 events per h |
|||
---|---|---|---|---|---|---|---|---|---|---|
Men | Women | Men | Women | |||||||
Australia24 | 380 | 2008 | 40–65 | 73% | AASM 2012 | Yes | 25·5% | 23·5% | 4·7% | 4·9% |
Brazil25 | 1042 | 2010 | 20–80 | 45% | AASM 2007 | Yes | 46·5% | 30·6% | 24·8% | 9·6% |
China38 | 3648 | 2005 | ≥20 | 50% | Chicago 1999 | Unspecified | 24·2% | 24·2% | 9·5% | 9·5% |
Germany39 | 1208 | 2018 | 20–81 | 54% | AASM 2007 | Yes | 59·4% | 33·2% | 29·7% | 13·2% |
Hong Kong27 | 153 | 2001 | 30–60 | 100% | AASM 2007 | No | 8·8% | ·· | 5·3% | ·· |
Hong Kong28 | 106 | 2004 | 30–60 | 0% | AASM 2007 | No | ·· | 3·7% | ·· | 1·9% |
Iceland29 | 415 | 2016 | 40–65 | ·· | AASM 2007 | Yes | 13·3% | 10·8% | 10·6% | 4·8% |
India30 | 365 | 2009 | 30–65 | ·· | Chicago 1999 | Yes | 13·5% | 6·1% | 5·5% | 6·1% |
Japan32 | 322 | 2008 | 23–59 | ·· | AASM 2012 | Yes | 59·7% | ·· | 22·3% | ·· |
New Zealand31 | 364 | 2009 | 30–59 | ·· | AASM 2007 | Yes | 12·5% | 3·4% | 3·9% | 0·2% |
Norway33 | 518 | 2011 | 30–65 | 55% | AASM 2007 | No | 21·0% | 13·0% | 11·0% | 6·0% |
Poland34 | 676 | 2008 | 41–72 | 54% | AASM 2007 | Yes | 36·2% | 18·4% | 15·8% | 7·6% |
South Korea35 | 457 | 2004 | 40–69 | 69% | AASM 2007 | No | 27·1% | 16·8% | 10·1% | 4·7% |
Singapore36 | 242 | 2016 | 21–79 | 50% | AASM 2007 | Yes | 62·3% | 62·3% | 26·1% | 26·1% |
Singapore36 | 242 | 2016 | 21–79 | 50% | AASM 2012 | Yes | 70·8% | 70·8% | 30·5% | 30·5% |
Spain37 | 2148 | 2001 | 30–70 | 49% | AASM 2007 | No | 26·2% | 28·0% | 14·2% | 7·0% |
Switzerland23 | 2121 | 2015 | 40–85 | 48% | AASM 2012 | Yes | 83·8% | 60·8% | 49·7% | 23·4% |
USA26 | 1520 | 2013 | 30–70 | 55% | AASM 2007 | Yes | 33·9% | 17·4% | 13·0% | 6·0% |
Based on two different apnoea-hypopnoea index (AHI) cutoff values.